CLN8 Antikörper (N-Term)
-
- Target Alle CLN8 Antikörper anzeigen
- CLN8 (Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Hund, Pferd, Affe
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CLN8 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Human CLN8
- Homologie
- Percent identity by BLAST analysis: Human, Dog, Horse (100%).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide from N-Terminus of human CLN8 (Q9UBY8, NP_061764). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Monkey, Galago, Dog, Horse (100%), Gibbon, Panda (92%), Marmoset, Guinea pig (85%).
Type of Immunogen: Synthetic peptide - Isotyp
- IgG
- Top Product
- Discover our top product CLN8 Primärantikörper
-
anti-Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) antibody
CLN8 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) (AA 247-286) antibodyCLN8 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) (AA 201-286) antibodyCLN8 Reaktivität: Human, Ratte WB, ELISA, IF (cc), IF (p), IHC (fro), IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) (AA 251-280), (C-Term) antibodyCLN8 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB35588 unconjugated
anti-Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) (AA 72-121) antibodyCLN8 Reaktivität: Human, Hund, Maus, Rind (Kuh) WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Approved: WB
Usage: ELISA titer using peptide based assay: 1:12500. Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1:50000 - 100000 as second antibody. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Distilled Water.
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Handhabung
- Avoid repeat freeze-thaw cycles.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Target
- CLN8 (Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
- Andere Bezeichnung
- CLN8 (CLN8 Produkte)
- Synonyme
- mnd antikoerper, C8orf61 antikoerper, EPMR antikoerper, CLN8, transmembrane ER and ERGIC protein antikoerper, ceroid-lipofuscinosis, neuronal 8 antikoerper, CLN8 antikoerper, Cln8 antikoerper
- Hintergrund
-
Name/Gene ID: CLN8
Synonyms: CLN8, EPMR, Protein CLN8, C8orf61 - Gen-ID
- 2055
- NCBI Accession
- NP_061764
- UniProt
- Q9UBY8
- Pathways
- Regulation of Cell Size, Dicarboxylic Acid Transport
-
